<DOC>
	<DOCNO>NCT01121601</DOCNO>
	<brief_summary>Study phase II : Clinical study national , exploratory , multicentric , prospective , randomize , double blind man evaluate effectiveness tolerance treatment surgical gel seal contain polyethylene glycol prevention operational adherence post.3 Study phase III : Clinical study national , multicentric , prospective , randomize , control , double blind man compare group control group patient treat surgical gel seal contain polyethylene glycol prevention hepatic adherence novo post operational .</brief_summary>
	<brief_title>CoSeal Liver Biliary Surgery Prevention Denovo Hepatic Adhesion</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>Major patient . Hepatic Carriers metastasis . Eligible procedure surgical eradication two bring close time ( time lower 3 month ) . Strategy validate multidisciplinary meeting cancerology . Enlightened Assent give sign intervention . Anaesthetic Counterindications procedure two time Carcinose péritonéale , reach metastatic éradicable Oversensitiveness allergy know polyethylene CoSeal glycol Concomitant Use another antiblocking agent Immunodéprimés Patients take drug immunodépresseurs long court like corticosteroid , Impossibility subject medical monitoring impose study reason geographical , social , psychic medical . Concomitant Participation another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>